» Articles » PMID: 38748203

Laser Ablation for Spongiform Thyroid Nodules: Identifying Baseline Nodule Volume and Energy to Be Delivered for Successful Treatment

Overview
Journal Endocrine
Specialty Endocrinology
Date 2024 May 15
PMID 38748203
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Laser ablation (LA) is a minimally invasive treatment. It has been widely used since the early 2000s to induce volume reduction of symptomatic benign thyroid nodules. Up to 40% of laser-treated nodules have been reported to achieve a volume reduction of <50% (technique inefficacy) at 12 months and tend to regrow over time.

Objective: This study aimed to assess the optimal baseline volume and energy to be delivered to minimize technique inefficacy.

Methods: This was a retrospective study. Data were collected, including baseline volume, energy delivered, and 12-month volume reduction ratio (VRR) of spongiform nodules (EU-TIRADS 2) treated with LA between 2010 and 2020. Based on these data, the optimal baseline volume and energy to be delivered were calculated to maximize the rate of nodules with technique efficacy (VRR ≥ 50% at 12-month follow-up).

Results: A total of 205 patients with spongiform nodules were included in this study. The energy delivered was positively associated with VRR. However, no association was observed between baseline volume and VRR. Delivering energy ≥500 J/mL to nodules with a mean baseline volume of 11.4 ± 4 mL resulted in technique efficacy in 83% of cases.

Conclusion: Treating spongiform nodules with a baseline volume of ≤15 mL and delivering energy ≥500 J/mL are key factors for achieving a relevant rate of technique efficacy.

References
1.
Knudsen N, Perrild H, Christiansen E, Rasmussen S, Dige-Petersen H, Jorgensen T . Thyroid structure and size and two-year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. Eur J Endocrinol. 2000; 142(3):224-30. DOI: 10.1530/eje.0.1420224. View

2.
Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R . Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid. 2005; 14(11):926-32. DOI: 10.1089/thy.2004.14.926. View

3.
Kwong N, Medici M, Angell T, Liu X, Marqusee E, Cibas E . The Influence of Patient Age on Thyroid Nodule Formation, Multinodularity, and Thyroid Cancer Risk. J Clin Endocrinol Metab. 2015; 100(12):4434-40. PMC: 4667162. DOI: 10.1210/jc.2015-3100. View

4.
Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, Paciaroni A . The natural history of benign thyroid nodules. JAMA. 2015; 313(9):926-35. DOI: 10.1001/jama.2015.0956. View

5.
Negro R . What happens in a 5-year follow-up of benign thyroid nodules. J Thyroid Res. 2014; 2014:459791. PMC: 4236885. DOI: 10.1155/2014/459791. View